| GOLDMAN SACHS JAPAN EQUITY PARTNERS PORTFOLIO I H EUR CAP | RVI JAPÓN | 30,40% | 87,20% | 119,07% | 360,28% |
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | RVI BIOTECNOLOGÍA | 60,60% | 103,57% | 101,69% | 360,14% |
| POLAR CAPITAL JAPAN VALUE R EUR DIS HEDGED | RVI JAPÓN VALOR | 51,61% | 132,71% | 205,31% | 360,13% |
| CHALLENGE TECHNOLOGY EQUITY EVOLUTION S-A | RVI TECNOLOGÍA | 31,12% | 104,80% | 77,61% | 359,69% |
| LORD ABBETT INNOVATION GROWTH FUND Z USD CAP | RVI GLOBAL CRECIMIENTO | 11,93% | 96,31% | 54,00% | 359,27% |
| JPM US GROWTH D (ACC) USD | RVI USA CRECIMIENTO | 6,54% | 59,47% | 56,13% | 358,54% |
| PRIVILEDGE - ALPHA JAPAN (CHF) P CAP SYST. HDG | RVI JAPÓN | 29,00% | 96,58% | 157,45% | 358,17% |
| JPM TAIWAN D (ACC) USD | RVI CHINA | 87,92% | 178,13% | 141,69% | 357,29% |
| PRIVILEDGE - ALPHA JAPAN (EUR) M CAP SYST. HDG | RVI JAPÓN | 32,50% | 109,04% | 150,27% | 357,18% |
| GOLDMAN SACHS JAPAN EQUITY PARTNERS PORTFOLIO R H EUR CAP | RVI JAPÓN | 30,33% | 86,72% | 118,18% | 356,61% |
